Return to search results.
Complete title: A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of AGS15E Given as Monotherapy in Subjects with Metastatic Urothelial Cancer
|Research Study Number||20140069|
|Principal Investigator||Evan Yu, MD|
Research Study Description
Eligibility Criteria (must meet the following to participate in this study)
Other eligibility criteria may apply.
Genitourinary Cancer; Solid Tumors; Urethral Cancer; Immunotherapy
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.